The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM IN BRIEF: Quindell And ValiRx Placings; Noricum Gold Positive Results

Fri, 15th Nov 2013 07:53

LONDON (Alliance News) - The following AIM-listed companies are making headlines on Alliance News Professional at the market open Friday:
----------
Quindell Portfolio Raises GBP200M Through Share Placing
----------
Bglobal Enters Agreement With Future Energy Solutions For Nutech Training
----------
Northbridge Industrial Services Acquires Assets of Oilfield Material Management For USD3M
----------
Armadale Capital To Buy Rest Of Netcom Global; Deal Gives It 80% Interest In Mpokoto Gold Project
----------
London Capital Finance Director Steps Down; Appoints Interim Finance Chief While It Looks For Successor
----------
Physiomics FY Turnover Up 77% To GBP240,000 Vs GBP135,306; Operating Loss Of GBP548,342 Vs GBP577,922; FY Net Loss Of GBP500,571 Vs GBP539,577; Signed A SEDA Structured Equity Deal, Won A Feasibility Grant
----------
Parkmead Group FY Pretax Loss GBP5.3M Vs GBP4.9M; Revenue Up 38% To GBP4.1 Million; FY Total Assets GBP53.4M Vs GBP22.9M; In Advanced Talks With Debt Lenders
----------
Noricum Gold: Results Continue To Reinforce High Grade Nature Of Rotguloden Project ; Visible Gold Intersected In Drill Hole C9; Drilling On-Going Underground; Looks Forward To Further Positives In Near Future
----------
GW Phamaceuticals Orphan Drug Designation Granted For Epidiolex In Dravet Syndrome By FDA
----------
Touchstone Gold Q3 Net Loss USD499,350 Vs USD2.3M; 9-Mo Net Loss USD16.9M Vs USD7.7M
----------
ValiRx To Raises GBP1M Through Share Placing
----------
Doriemus Reorganises Board, Don Strang New Chairman
----------
Frontier IP Makes New Spin-Out Company With Plymouth University; Receives 21% Stake In New Spin-Out Company PulsiV Solar
----------
Matchtech Chairman: Q1 Trading In Line With Board Expectations; Demand For Contract Recruitment Continues To Grow; Seeing First Signs Of Permanent Candidate Confidence Returning; Q1 Net Fee Income Of GBP11.1M, Up 13%; Looks Forward With Confidence To The Year Ahead
----------
Pantheon Resources FY Loss GBP700,095 Vs GBP703,602
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
24 Jul 2020 17:23

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

Read more
23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

Read more
16 Jul 2020 15:57

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
6 Jul 2020 18:19

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

Read more
6 Jul 2020 09:31

ValiRx looks to build on portfolio of drug candidates

(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.

Read more
1 Jul 2020 13:10

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

Read more
16 Jun 2020 13:58

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

Read more
8 Jun 2020 15:39

ValiRx Delays Annual Results Amid Covid-19 Pandemic

ValiRx Delays Annual Results Amid Covid-19 Pandemic

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
2 Jun 2020 12:03

ValiRx enters collaboration agreement for Covid-19 treatment

(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.

Read more
29 May 2020 15:02

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App

Read more
29 May 2020 12:59

ValiRx offloads non-core IP to DDTech

(Sharecast News) - ValiRx has entered into a deed of assignment with Drug Discovery Technologies (DDTech) for the patents, materials and know-how associated with its non-core intellectual property 'FitBio' and 'TRAC', it announced on Friday.

Read more
27 May 2020 14:20

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair

Read more
7 May 2020 14:45

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair

Read more
4 May 2020 16:18

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.